While this trial demonstrated semaglutide's superiority, it also confirmed that liraglutide produces clinically meaningful weight loss that exceeds lifestyle changes alone
Standards of Care in Diabetes-2023
Market Opportunity Mapping A comparative analysis of obesity prevalence and healthcare expenditure per capita provides valuable insights into target markets for obesity therapeutics
Heres everything I found: OrderlyMeds posts a flat $149/mo for compounded semaglutide and $299/mo for compounded tirzepatide right on the pricing tab
A large JAMA Surgery study found that over 2 years, mean total costs were higher for GLP-1 receptor agonists than for metabolic/bariatric surgery: about $63,483 for GLP-1 therapy vs $51,794 for surgery
While there are no studies beyond that, its likely that the benefits can last much longer, even at two years time, as a recommendation has been made to repeat the Botox injection every 1-2 years if needed